国家: 爱尔兰
语言: 英文
来源: HPRA (Health Products Regulatory Authority)
Cetirizine hydrochloride
UCB (Pharma) Ireland Limited
R06AE; R06AE07
Cetirizine hydrochloride
10 milligram(s)
Film-coated tablet
Product not subject to medical prescription
Piperazine derivatives; cetirizine
Marketed
1988-08-08
PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRTEK 10 MG FILM-COATED TABLETS Cetirizine dihydrochloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET : 1. What Zirtek is and what it is used for 2. What you need to know before you take Zirtek 3. How to take Zirtek 4. Possible side effects 5. How to store Zirtek 6. Contents of the pack and other information 1. WHAT ZIRTEK IS AND WHAT IT IS USED FOR Cetirizine dihydrochloride is the active ingredient of Zirtek. Zirtek is an antiallergic medication. In adults and children aged 6 years and above, Zirtek 10 mg film-coated tablets are indicated - for the relief of nasal and ocular symptoms of seasonal and perennial allergic rhinitis. - for the relief of urticaria. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ZIRTEK DO NOT TAKE ZIRTEK - if you have a severe kidney disease requiring dialysis; - if you are allergic to cetirizine dihydrochloride, to any of the other ingredients (listed in section 6), to hydroxyzine or to piperazine derivatives (closely related active ingredients of other medicines). WARNING AND PRECAUTIONS Talk to your doctor or pharmacist before taking Zirtek. If you are a patient with renal insufficiency, please ask your doctor for advice; if necessary, you will take a lower dose. The new dose will be determined by your doctor. If you have problems passing urine (like spinal cord problems or prostate or bladder problems), please ask your doctor for advice. If you are an epileptic patient or a patient at risk of convulsions, you should ask your docto 阅读完整的文件
Health Products Regulatory Authority 02 October 2023 CRN00DGKH Page 1 of 9 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Zirtek 10 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 10 mg cetirizine dihydrochloride. Excipients with known effect: one film-coated tablet contains 66.40 mg lactose monohydrate. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablets White, oblong, film-coated tablet, with breakline and Y-Y logo. The tablet can be divided into 2 equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Cetirizine dihydrochloride 10 mg film-coated tablets are indicated in adults and paediatric patients 6 years and above: - for the relief of nasal and ocular symptoms of seasonal and perennial allergic rhinitis. - for the relief of symptoms of chronic idiopathic urticaria. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology 10 mg once daily (1 tablet). Special population _Elderly_ Data do not suggest that the dose needs to be reduced in elderly subjects provided that the renal function is normal. _Renal impairment_ There are no data to document the efficacy/safety ratio in patients with renal impairment. Since cetirizine is mainly excreted via renal route (see section 5.2), in cases no alternative treatment can be used, the dosing intervals must be individualized according to renal function. Refer to the following table and adjust the dose as indicated. Dosing adjustments for adult patients with impaired renal function Group Estimated Glomerular Filtration Rate (eGFR) (ml/min) Dosage and frequency Normal renal function >90 10 mg once daily Mildly decreased renal function 60 - < 90 10 mg once daily Moderately decreased renal function 30 – < 60 5 mg once daily Severely decreased renal function 15 - <30 not requiring dialysis treatment 5 mg once every 2 days End-stage renal disease <15 requiring dialysis treatment Contraindicated _Hepatic impairment_ Health Products Regulatory Authority 02 October 阅读完整的文件